Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Ascendis Pharma authorises $400M share buyback after revenue surges 105%
Dealroom.co1 min read
Ascendis Pharma authorises $400M share buyback after revenue surges 105% Dealroom
Read the full article at Dealroom.coRelated coverage
Stock Market Today Highlights, Sept 2: Sensex ends 373 pts lower at 76, 570, Nifty below 24, 000; Asian Paints, HDFC Bank fall most
thehindubusinessline.com · Sep 2, 2026
Nvidia boosts share buyback program by record $150B
SiliconANGLE · Sep 28, 2026
Rep . Dan Newhouse Sells Off NVIDIA Corporation ( NASDAQ : NVDA ) Shares
themarketsdaily.com · Jul 21, 2026
Chips & Infra
This Week in AI Stocks : The $750 Billion Capex Wave and Where the Real Bottlenecks Are
livetradingnews.com · Jul 31, 2026